Tobin D, Vuckovic A, Sarris J
Nutrients. 2024; 16(16).
PMID: 39203943
PMC: 11357244.
DOI: 10.3390/nu16162806.
Sarkisova K, Gabova A, Fedosova E, Shatskova A, Narkevich V, Kudrin V
Int J Mol Sci. 2023; 24(15).
PMID: 37569798
PMC: 10419169.
DOI: 10.3390/ijms241512425.
Channer B, Matt S, Nickoloff-Bybel E, Pappa V, Agarwal Y, Wickman J
Pharmacol Rev. 2023; 75(1):62-158.
PMID: 36757901
PMC: 9832385.
DOI: 10.1124/pharmrev.122.000618.
Macaluso M
Front Psychiatry. 2022; 13:840116.
PMID: 35370812
PMC: 8968318.
DOI: 10.3389/fpsyt.2022.840116.
Lucido M, Bekhbat M, Goldsmith D, Treadway M, Haroon E, Felger J
Pharmacol Rev. 2021; 73(3):1084-1117.
PMID: 34285088
PMC: 11060479.
DOI: 10.1124/pharmrev.120.000043.
Serum folate levels in bipolar disorder: a systematic review and meta-analysis.
Hsieh Y, Chou L, Lin C, Wu H, Li D, Tseng P
BMC Psychiatry. 2019; 19(1):305.
PMID: 31640634
PMC: 6805488.
DOI: 10.1186/s12888-019-2269-2.
Screening in Treatment-Resistant Depression.
Kandler C, Lam S
Fed Pract. 2019; 36(5):207-208.
PMID: 31138974
PMC: 6530664.
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.
Felger J
Curr Neuropharmacol. 2017; 16(5):533-558.
PMID: 29173175
PMC: 5997866.
DOI: 10.2174/1570159X15666171123201142.
Nature's hydrides: rapid reduction of halocarbons by folate model compounds.
Denk M, Milutinovic N, Marczenko K, Sadowski N, Paschos A
Chem Sci. 2017; 8(3):1883-1887.
PMID: 28553478
PMC: 5424806.
DOI: 10.1039/c6sc04314c.
Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study.
Nembhard W, Tang X, Hu Z, MacLeod S, Stowe Z, Webber D
BMJ. 2017; 356:j832.
PMID: 28264803
PMC: 6283388.
DOI: 10.1136/bmj.j832.
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.
Felger J, Treadway M
Neuropsychopharmacology. 2016; 42(1):216-241.
PMID: 27480574
PMC: 5143486.
DOI: 10.1038/npp.2016.143.
The glutathione system: a new drug target in neuroimmune disorders.
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M
Mol Neurobiol. 2014; 50(3):1059-84.
PMID: 24752591
DOI: 10.1007/s12035-014-8705-x.
Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial.
Shelton R, Manning J, Barrentine L, Tipa E
Prim Care Companion CNS Disord. 2014; 15(4).
PMID: 24392264
PMC: 3869616.
DOI: 10.4088/PCC.13m01520.
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.
Felger J, Lotrich F
Neuroscience. 2013; 246:199-229.
PMID: 23644052
PMC: 3741070.
DOI: 10.1016/j.neuroscience.2013.04.060.
Efficacy and cost of micronutrient treatment of childhood psychosis.
Rodway M, Vance A, Watters A, Lee H, Bos E, Kaplan B
BMJ Case Rep. 2012; 2012.
PMID: 23144350
PMC: 4543964.
DOI: 10.1136/bcr-2012-007213.
Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
Felger J, Li L, Marvar P, Woolwine B, Harrison D, Raison C
Brain Behav Immun. 2012; 31:153-60.
PMID: 23072726
PMC: 3578984.
DOI: 10.1016/j.bbi.2012.10.010.
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.
Felger J, Miller A
Front Neuroendocrinol. 2012; 33(3):315-27.
PMID: 23000204
PMC: 3484236.
DOI: 10.1016/j.yfrne.2012.09.003.
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.
Haroon E, Raison C, Miller A
Neuropsychopharmacology. 2011; 37(1):137-62.
PMID: 21918508
PMC: 3238082.
DOI: 10.1038/npp.2011.205.
Complementary and alternative medicine for the treatment of major depressive disorder.
Nahas R, Sheikh O
Can Fam Physician. 2011; 57(6):659-63.
PMID: 21673208
PMC: 3114664.
L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode.
Ginsberg L, Oubre A, Daoud Y
Innov Clin Neurosci. 2011; 8(1):19-28.
PMID: 21311704
PMC: 3036555.
